MedTrace Logo

Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Depression

NCT05772702 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2025-05-29

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to study closed-loop transcranial alternating current stimulation (tACS) to determine its effects on symptoms of depression in people with major depressive disorder.

Conditions

Interventions

DEVICE

Closed-loop tACS

Individual alpha tACS

Sponsors & Collaborators

  • University of North Carolina, Chapel Hill

    collaborator OTHER

  • Electromedical Products International, Inc.

    lead INDUSTRY

Principal Investigators

  • David R Rubinow, MD · University of North Carolina, Chapel Hill

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-13
Primary Completion
2024-04-22
Completion
2024-08-19
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05772702 on ClinicalTrials.gov